MyMyelomaTeam

The progression rate from Stage II to Stage III myeloma can vary significantly between individuals. The staging is based on specific measurements rather than time, including:

- Beta-2 microglobulin levels
- Albumin levels
- Lactate dehydrogenase (LDH) levels
- Genetic abnormalities in myeloma cells Stage III is diagnosed Show Full Answer

The progression rate from Stage II to Stage III myeloma can vary significantly between individuals. The staging is based on specific measurements rather than time, including:

- Beta-2 microglobulin levels
- Albumin levels
- Lactate dehydrogenase (LDH) levels
- Genetic abnormalities in myeloma cells Stage III is diagnosed when beta-2 microglobulin levels reach 5.5 milligrams per liter or higher, along with either high-risk chromosome abnormalities or elevated LDH levels. The progression speed depends on individual factors, treatment response, and overall health status. Regular monitoring of these markers helps track disease progression.

It's important to work closely with your healthcare team to monitor these levels and adjust treatment plans as needed.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Stage 2 Multiple Myeloma Prognosis: Fear, Hope, and Understanding Survival Rates

Stage 3 Multiple Myeloma: Outlook and Survival